Open Access iconOpen Access

VIEWPOINT

crossmark

Co-regulator NCOA5 and cancer

YUANYUAN CHEN, SHUAISHUAI CUI, YUNFEI GUO, DAHU CHEN*

School of Life Sciences, Shandong University of Technology, Zibo, 225000, China

* Corresponding Author: Dahu Chen, email

(This article belongs to the Special Issue: Biochemical and Epigenetics Changes in Health and Disease)

BIOCELL 2022, 46(7), 1643-1650. https://doi.org/10.32604/biocell.2022.019142

Abstract

NCOA5 encodes a co-regulator for estrogen receptors (ERα and ERβ), orphan nuclear receptors (REV-ERBα and REV-ERBβ) and liver X receptor. It can influence many cellular processes by either promoting or inhibiting gene expression through its two important functional motifs: LxxLL (co-activator) and ΦxxΦΦ (co-repressor). Many reports have revealed the important roles of NCOA5 in diseases, such as diabetes, reproductive defects and autoimmune disease. In this review, we focus on its function in cancers and summary the current research progresses regarding its different roles in various cancers.

Keywords


Cite This Article

APA Style
CHEN, Y., CUI, S., GUO, Y., CHEN, D. (2022). Co-regulator NCOA5 and cancer. BIOCELL, 46(7), 1643-1650. https://doi.org/10.32604/biocell.2022.019142
Vancouver Style
CHEN Y, CUI S, GUO Y, CHEN D. Co-regulator NCOA5 and cancer. BIOCELL . 2022;46(7):1643-1650 https://doi.org/10.32604/biocell.2022.019142
IEEE Style
Y. CHEN, S. CUI, Y. GUO, and D. CHEN, “Co-regulator NCOA5 and cancer,” BIOCELL , vol. 46, no. 7, pp. 1643-1650, 2022. https://doi.org/10.32604/biocell.2022.019142



cc Copyright © 2022 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 2001

    View

  • 971

    Download

  • 1

    Like

Related articles

Share Link